LODATO, FRANCESCA
LODATO, FRANCESCA
LODATO F; F.LODATO; LODATO
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy
2016 Lodato, Francesca; Poluzzi, Elisabetta; Raschi, Emanuel; Piccinni, Carlo; Koci, Ariola; Olivelli, Valentina; Napoli, Chiara; Corvalli, Giulia; Nalon, Elena; De Ponti, Fabrizio; Zoli, Marco
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease
2011 Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Ceciinato P, Calvanese C, Lodato F, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease
2011 Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Cecinato P, Calvanese C, Lodato F, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease.
2011 Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Cecinato P, Calvanese C, Lodato F, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease.
2011 Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Cecinato P, Calvanese C, Lodato F, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis
2011 Turco L, Azzaroli F, Buonfiglioli F, Simoni P, Lisotti A, Cecinato P, Calvanese C, Lodato F, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis.
2011 Turco L, Azzaroli F, Buonfiglioli F, Lisotti A, Cecinato P, Calvanese C, Lodato F, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G
Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis.
2011 Turco L, Azzaroli F, Buonfiglioli F, Lisotti A, Cecinato P, Montagnani M, Calvanese C, Lodato F, Golfieri R, Colecchia A, Festi D, Mazzella G
Adverse effects of proton pump inhibitors.
2010 Lodato F; Azzaroli F; Turco L; Mazzella N; Buonfiglioli F; Zoli M; Mazzella G.
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease
2010 Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Simoni P, Cecinato P, Calvanese C, Lodato F, Montagnani M, Golfieri R, Colecchia A, Festi D, Mazzella G
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study
2010 Biselli M; Gramenzi A; Del Gaudio M; Ravaioli M; Vitale G; Gitto S; Grazi GL; Pinna AD; Andreone P; Bernardi M; and Bologna Liver Transplantation Group.
UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY
2010 F. Azzaroli; A. Mennone; M.E. Raspanti; M.L. Longo; M. Montagnani; L. Turco; F. Buonfiglioli; M. Giandinoto; F. Lodato; E. Roda; A. Lisotti; P. Cecinato; J.L.Boyer; G. Mazzella
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY
2009 F. Alessandrelli; F. Azzaroli; V. Feletti; A. Lisotti; F. Buonfiglioli; M. Montagnani; A. Colecchia; D. Festi; F. Lodato; E. Roda; G. Mazzella
G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence
2009 Lodato F; Azzaroli F; Tamè MR; Di Girolamo M; Buonfiglioli F; Mazzella N; Cecinato P; Roda E; Mazzella G
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE
2009 Buonfiglioli f; Azzaroli F; Montagnani M;Simoni P; Locatelli M; Raspanti ME; Lisotti A; Lodato F; Alessandrelli F; Colecchia A; Festi D; Roda A; Roda E; Mazzella G
Outcomes and survival after TIPS positioning: a single center experience
2009 Baldini M, Golfieri R, Azzaroli F, Lodato F, Giampalma E, Cappelli A, Buonfiglioli F, Renzulli M, Mosconi C, Alessandrelli F, Mazzella G
Outcomes and survival after TIPS positioning: a single center experience
2009 Baldini M, Golfieri R, Azzaroli F, Lodato F, Giampalma E, Cappelli A, Buonfiglioli F, Renzulli M, Mosconi C, Alessandrelli F, Mazzella G
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation
2008 Lodato F; Berardi S; Gramenzi A; Mazzella G; Lenzi M; Morelli MC; Tame MR; Piscaglia F; Andreone P; Bologna Liver Transplantation Group (BLTG) [..; Ballardini G; Bernardi M; Bianchi FB; Biselli M; Bolondi L; Cescon M; Colecchia A; D'Errico A; Del Gaudio M; Ercolani G; Grazi GL; Grigioni W; Lorenzini S; Pinna AD; Ravaioli M; Roda E; Sama C; Vivarelli M.; ..]
Effect of combined IFN-Alpha/Ribavirin Treatment in HCV disease-related progression
2008 D.Festi;F.Lodato;G.Mazzella;A.Colecchia
G-CSF administration is not related to PEG-IFN alfa-213 treatment duration nor response in liver transplanted patients with HCV recurrence
2008 Lodato F ; Tame MR ; Di Girolamo M ; Azzaroli F; Gramenzi A ; Berardi S ; Andreone P ; Pinna AD ; Roda E ; Mazzella G .
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy | Lodato, Francesca; Poluzzi, Elisabetta; Raschi, Emanuel; Piccinni, Carlo; Koci, Ariola; Olivelli,... Valentina; Napoli, Chiara; Corvalli, Giulia; Nalon, Elena; De Ponti, Fabrizio; Zoli, Marco | 2016-01-01 | EUROPEAN JOURNAL OF INTERNAL MEDICINE | - | 1.01 Articolo in rivista | - |
| Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease | Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Ceciinato P, Calvanese C, Lodato F, Montagnani M,... Golfieri R, Colecchia A, Festi D, Mazzella G | 2011-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease | Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Cecinato P, Calvanese C, Lodato F, Montagnani M, ...Golfieri R, Colecchia A, Festi D, Mazzella G | 2011-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. | Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Cecinato P, Calvanese C, Lodato F, Montagnani M, ...Golfieri R, Colecchia A, Festi D, Mazzella G | 2011-01-01 | GASTROENTEROLOGY | - | 1.06 Abstract in rivista | - |
| Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. | Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Cecinato P, Calvanese C, Lodato F, Montagnani M, ...Golfieri R, Colecchia A, Festi D, Mazzella G | 2011-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis | Turco L, Azzaroli F, Buonfiglioli F, Simoni P, Lisotti A, Cecinato P, Calvanese C, Lodato F, Mont...agnani M, Golfieri R, Colecchia A, Festi D, Mazzella G | 2011-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. | Turco L, Azzaroli F, Buonfiglioli F, Lisotti A, Cecinato P, Calvanese C, Lodato F, Montagnani M, ...Golfieri R, Colecchia A, Festi D, Mazzella G | 2011-01-01 | GASTROENTEROLOGY | - | 1.06 Abstract in rivista | - |
| Indocyanine green clearance as a marker of decompensation and clinically significant portal hypertension in patients with liver cirrhosis. | Turco L, Azzaroli F, Buonfiglioli F, Lisotti A, Cecinato P, Montagnani M, Calvanese C, Lodato F, ...Golfieri R, Colecchia A, Festi D, Mazzella G | 2011-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| Adverse effects of proton pump inhibitors. | Lodato F; Azzaroli F; Turco L; Mazzella N; Buonfiglioli F; Zoli M; Mazzella G. | 2010-01-01 | BAILLIERE'S BEST PRACTICE & RESEARCH. CLINICAL GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease | Lisotti A, Azzaroli F, Turco L, Buonfiglioli F, Simoni P, Cecinato P, Calvanese C, Lodato F, Mont...agnani M, Golfieri R, Colecchia A, Festi D, Mazzella G | 2010-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study | Biselli M; Gramenzi A; Del Gaudio M; Ravaioli M; Vitale G; Gitto S; Grazi GL; Pinna AD; Andreone ...P; Bernardi M; and Bologna Liver Transplantation Group. | 2010-01-01 | JOURNAL OF CLINICAL GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| UDCA UP-REGULATES HUMAN PLACENTAL OATP-A EXPRESSION IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY |
F. Azzaroli; A. Mennone; M.E. Raspanti; M.L. Longo; M. Montagnani; L. Turco; F. Buonfiglioli; M.... Giandinoto; F. Lodato; E. Roda; A. Lisotti; P. Cecinato; J.L.Boyer; G. Mazzella |
2010-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY | F. Alessandrelli; F. Azzaroli; V. Feletti; A. Lisotti; F. Buonfiglioli; M. Montagnani; A. Colecch...ia; D. Festi; F. Lodato; E. Roda; G. Mazzella | 2009-01-01 | JOURNAL OF HEPATOLOGY | - | 4.02 Riassunto (Abstract) | - |
| G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence |
Lodato F; Azzaroli F; Tamè MR; Di Girolamo M; Buonfiglioli F; Mazzella N; Cecinato P; Roda E; Ma...zzella G |
2009-01-01 | WORLD JOURNAL OF GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE | Buonfiglioli f; Azzaroli F; Montagnani M;Simoni P; Locatelli M; Raspanti ME; Lisotti A; Lodato F;... Alessandrelli F; Colecchia A; Festi D; Roda A; Roda E; Mazzella G | 2009-01-01 | JOURNAL OF HEPATOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Outcomes and survival after TIPS positioning: a single center experience | Baldini M, Golfieri R, Azzaroli F, Lodato F, Giampalma E, Cappelli A, Buonfiglioli F, Renzulli M,... Mosconi C, Alessandrelli F, Mazzella G | 2009-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| Outcomes and survival after TIPS positioning: a single center experience | Baldini M, Golfieri R, Azzaroli F, Lodato F, Giampalma E, Cappelli A, Buonfiglioli F, Renzulli M,... Mosconi C, Alessandrelli F, Mazzella G | 2009-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation | Lodato F; Berardi S; Gramenzi A; Mazzella G; Lenzi M; Morelli MC; Tame MR; Piscaglia F; Andreone ...P; Bologna Liver Transplantation Group (BLTG) [..; Ballardini G; Bernardi M; Bianchi FB; Biselli M; Bolondi L; Cescon M; Colecchia A; D'Errico A; Del Gaudio M; Ercolani G; Grazi GL; Grigioni W; Lorenzini S; Pinna AD; Ravaioli M; Roda E; Sama C; Vivarelli M.; ..] | 2008-01-01 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| Effect of combined IFN-Alpha/Ribavirin Treatment in HCV disease-related progression | D.Festi;F.Lodato;G.Mazzella;A.Colecchia | 2008-01-01 | - | Springer | 2.01 Capitolo / saggio in libro | - |
| G-CSF administration is not related to PEG-IFN alfa-213 treatment duration nor response in liver transplanted patients with HCV recurrence | Lodato F ; Tame MR ; Di Girolamo M ; Azzaroli F; Gramenzi A ; Berardi S ; Andreone P ; Pinna AD ;... Roda E ; Mazzella G . | 2008-01-01 | JOURNAL OF HEPATOLOGY | - | 4.02 Riassunto (Abstract) | - |